Marlio Charles Mosseri - 06 May 2025 Form 4/A - Amendment Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
06 May 2025
Net transactions value
+$247,263
Form type
4/A - Amendment
Filing time
12 May 2025, 09:25:24 UTC
Date Of Original Report
09 May 2025
Previous filing
11 Feb 2025
Next filing
13 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 12 May 2025 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $899 +100 +0% $8.99 2,909,032 08 May 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $871 +100 +0% $8.71 2,909,132 08 May 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $21,528 +2,400 +0.08% $8.97 2,911,532 08 May 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $88,128 +9,850 +0.34% $8.95 2,921,382 09 May 2025 By Emerald Hill Ventures SARL SPF. F1, F3
transaction NVCT Common Stock Purchase $87,412 +9,817 +0.34% $8.90 2,931,199 09 May 2025 By Emerald Hill Ventures SARL SPF. F1, F3
transaction NVCT Common Stock Purchase $48,426 +5,395 +0.18% $8.98 2,936,594 09 May 2025 By Emerald Hill Ventures SARL SPF. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
F2 The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions.
F3 The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025.